Search Results Search Sort by RelevanceMost Recent Policy Forum Mar 2004 Content of Medical Error Disclosures Thomas H. Gallagher, MD A basic standard for error disclosure for physicians needs to be developed, which will enhance the patient-physician relationship. Virtual Mentor. 2004;6(3):132-135. doi: 10.1001/virtualmentor.2004.6.3.pfor1-0403. In the Literature Mar 2004 Leap-Frogging to Forgiveness Faith Lagay, PhD A journal author calls for physicians to admit to and repent for their medical mistakes, even in a no-blame environment. Virtual Mentor. 2004;6(3):117-119. doi: 10.1001/virtualmentor.2004.6.3.jdsc1-0403. Case and Commentary Jul 2004 Limits of Youth Sports Training, Commentary 1 David T. Bernhardt, MD Physicians should attempt to monitor the training schedules of adolescent athletes to help ensure a balance between academics, friends, and sports. Virtual Mentor. 2004;6(7):293-297. doi: 10.1001/virtualmentor.2004.6.7.ccas1-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Limits of Youth Sports Training, Commentary 2 Lyle J. Micheli, MD Physicians should attempt to monitor the training schedules of adolescent athletes to help ensure a balance between academics, friends, and sports. Virtual Mentor. 2004;6(7):295-297. doi: 10.1001/virtualmentor.2004.6.7.ccas1-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Physicians are obligated to inform patients involved in a clinical trial that there is a chance of receiving a placebo, which can result in a deterioration of a medical condition. Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Pagination First page « First Previous page ‹ Previous … Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Current page 13 Page 14 Next page Next › Last page Last »
Policy Forum Mar 2004 Content of Medical Error Disclosures Thomas H. Gallagher, MD A basic standard for error disclosure for physicians needs to be developed, which will enhance the patient-physician relationship. Virtual Mentor. 2004;6(3):132-135. doi: 10.1001/virtualmentor.2004.6.3.pfor1-0403.
In the Literature Mar 2004 Leap-Frogging to Forgiveness Faith Lagay, PhD A journal author calls for physicians to admit to and repent for their medical mistakes, even in a no-blame environment. Virtual Mentor. 2004;6(3):117-119. doi: 10.1001/virtualmentor.2004.6.3.jdsc1-0403.
Case and Commentary Jul 2004 Limits of Youth Sports Training, Commentary 1 David T. Bernhardt, MD Physicians should attempt to monitor the training schedules of adolescent athletes to help ensure a balance between academics, friends, and sports. Virtual Mentor. 2004;6(7):293-297. doi: 10.1001/virtualmentor.2004.6.7.ccas1-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Limits of Youth Sports Training, Commentary 2 Lyle J. Micheli, MD Physicians should attempt to monitor the training schedules of adolescent athletes to help ensure a balance between academics, friends, and sports. Virtual Mentor. 2004;6(7):295-297. doi: 10.1001/virtualmentor.2004.6.7.ccas1-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Physicians can help oncology patients decide whether to focus on aggressive chemotherapy or less aggressive comfort measures for end-of-life care. Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Physicians are obligated to inform patients involved in a clinical trial that there is a chance of receiving a placebo, which can result in a deterioration of a medical condition. Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.